Viewing Study NCT02326194


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-03-06 @ 10:09 PM
Study NCT ID: NCT02326194
Status: COMPLETED
Last Update Posted: 2015-08-28
First Post: 2014-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: JSVCT020
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None INDUSTRY View